Email a Friend
Print ArticleAlzheimer's Disease Health Center
Experimental Alzheimer's Drug Halted
July 2, 2008 -- It's the end of the road for Flurizan, an experimental Alzheimer's disease drug, after disappointing results in its latest study.
Myriad Genetics, which was developing Flurizan, says it's discontinuing work on the drug.
In a preliminary study recently published in The Lancet, Flurizan looked like it might slow functional decline in Alzheimer's patients.
But in Flurizan's latest study -- an 18-month trial in patients with mild Alzheimer's disease -- Flurizan didn't meet the researchers' benchmark for its effects on cognition (mental skills) and daily activities.
del.icio.us
Motion Blindness and Alzheimer's
One of the symptoms of Alzheimer’s disease is disorientation. But it may not be just memory loss that’s causing the problem.
